The Company has three research and development facilities and six manufacturing facilities across India, North America, and Europe, supported by a 5,500+ strong global workforce. In the Radiopharma business, the company is involved in the manufacturing and supply of radiopharmaceutical products and services, with a network of 45 radiopharmacies in the United States (US).
Through its Allergy Immunotherapy business, the company is involved in manufacturing and supply of allergic extracts and sole supplier of venom products in the US.
Its CDMO Sterile Injectables business leads mid-sized contract manufacturer in North America, specialising in sterile fill-and finish injectables.
In the CRDMO business, the company is involved in integrated services spanning drug discovery, development and API manufacturing.